Suicide and Depression Clinical Trial
Official title:
Randomized Controlled Trial of an Online Machine Learning-Driven Risk Assessment and Intervention Platform for Increasing the Use of Crisis Services
Verified date | April 2023 |
Source | Harvard University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Objective: Mental illness is a leading cause of disease burden; however, many barriers prevent people from seeking mental health services. Technological innovations may improve the ability to reach under-served populations by overcoming many existing barriers. The investigators evaluated a brief, automated risk assessment and intervention platform designed to increase the use of crisis resources provided to individuals who were online and in crisis. Hypothesis: The investigators hypothesized that individuals assigned to the intervention condition would report using crisis resources at higher rates than individuals in the control condition. Method: Participants, users of the digital mental health app Koko, were randomly assigned to treatment or control conditions upon accessing the app and were included in the study after their posts were identified by machine learning classifiers as signaling a current mental health crisis. Participants in the treatment condition received a brief Barrier Reduction Intervention (BRI) designed to increase the use of crisis service referrals provided on the app. Participants were followed-up several hours later to assess the use of crisis services.
Status | Completed |
Enrollment | 39450 |
Est. completion date | September 20, 2017 |
Est. primary completion date | September 20, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Participants identified as experiencing a mental health crisis by a hybrid human-machine computation system evaluating semantic content of posts made on digital platforms. Exclusion Criteria: - Participants who were not identified as experiencing a mental health crisis. |
Country | Name | City | State |
---|---|---|---|
United States | Harvard University | Cambridge | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Harvard University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants Reporting Use of Crisis-referrals | The number participants indicating at follow-up that they used the crisis resources provided to them (e.g., called the suicide crisis hotline) | 5 hours post intervention | |
Secondary | Number of Participants in the Treatment Versus Control Conditions Reporting Their Experience Using Koko Was "Good" | The number of participants in the treatment versus control conditions reporting that their experience on the Koko digital platform was "good" versus "bad" using a two-option response question. | 5 hours post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04592809 -
Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
|
Phase 3 | |
Recruiting |
NCT05748730 -
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
|
N/A | |
Completed |
NCT04275908 -
Classification and Assessment of Mental Health Performance Using Schematics
|
||
Recruiting |
NCT06289842 -
Accelerated Theta Burst Stimulation for Treatment of Suicidality in Depressed Patients
|
N/A | |
Recruiting |
NCT04783506 -
Characterizing Inflammatory Profiles and Suicidal Behavior in Adolescents
|
||
Recruiting |
NCT03565562 -
Preventing Psychological Distress and Suicidal Behaviours: a Web-based and Mobile Suicide Prevention Intervention in the General Population
|
N/A |